Masafumi Seki

3.5k total citations
155 papers, 2.5k citations indexed

About

Masafumi Seki is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Masafumi Seki has authored 155 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Epidemiology, 61 papers in Infectious Diseases and 20 papers in Molecular Biology. Recurrent topics in Masafumi Seki's work include Pneumonia and Respiratory Infections (51 papers), Antifungal resistance and susceptibility (22 papers) and Respiratory viral infections research (20 papers). Masafumi Seki is often cited by papers focused on Pneumonia and Respiratory Infections (51 papers), Antifungal resistance and susceptibility (22 papers) and Respiratory viral infections research (20 papers). Masafumi Seki collaborates with scholars based in Japan, United States and France. Masafumi Seki's co-authors include Shigeru Kohno, Katsunori Yanagihara, Koichi Izumikawa, Yoshitsugu Miyazaki, Hiroshi Kakeya, Yoshihiro Yamamoto, Yoshifumi Imamura, Yoichi Hirakata, Akira Watanabe and Takayoshi Tashiro and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Masafumi Seki

140 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masafumi Seki Japan 27 1.2k 789 453 366 315 155 2.5k
Yoshitomo Morinaga Japan 24 901 0.7× 985 1.2× 438 1.0× 309 0.8× 218 0.7× 171 2.2k
Kazunori Tomono Japan 27 954 0.8× 1.1k 1.3× 484 1.1× 434 1.2× 182 0.6× 161 2.6k
June Myung Kim South Korea 32 1.2k 1.0× 876 1.1× 438 1.0× 297 0.8× 261 0.8× 202 3.6k
Wolfgang Graninger Austria 30 826 0.7× 802 1.0× 405 0.9× 213 0.6× 332 1.1× 105 2.8k
F. Jacobs Belgium 26 1.2k 1.0× 1.1k 1.4× 426 0.9× 271 0.7× 209 0.7× 62 2.5k
Hiroshi Kakeya Japan 31 1.9k 1.5× 1.9k 2.4× 669 1.5× 435 1.2× 208 0.7× 253 3.5k
Markos Marangos Greece 30 958 0.8× 942 1.2× 418 0.9× 246 0.7× 158 0.5× 180 2.9k
Yuka Yamagishi Japan 24 871 0.7× 752 1.0× 390 0.9× 147 0.4× 166 0.5× 213 2.3k
José L. Pérez Spain 24 1.1k 0.9× 695 0.9× 628 1.4× 456 1.2× 105 0.3× 91 3.0k
Raymond P. Smith United States 26 1.1k 0.9× 776 1.0× 530 1.2× 158 0.4× 239 0.8× 101 2.6k

Countries citing papers authored by Masafumi Seki

Since Specialization
Citations

This map shows the geographic impact of Masafumi Seki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masafumi Seki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masafumi Seki more than expected).

Fields of papers citing papers by Masafumi Seki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masafumi Seki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masafumi Seki. The network helps show where Masafumi Seki may publish in the future.

Co-authorship network of co-authors of Masafumi Seki

This figure shows the co-authorship network connecting the top 25 collaborators of Masafumi Seki. A scholar is included among the top collaborators of Masafumi Seki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masafumi Seki. Masafumi Seki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shinya, N., et al.. (2025). Infective native aortic and iliac artery aneurysms: Clinical profiles and short-term outcomes from a single-center cohort. Journal of Infection and Chemotherapy. 31(4). 102644–102644.
2.
Seki, Masafumi, et al.. (2024). Severe Respiratory Syncytial Virus Infections in Elderly Persons During the COVID-19 Pandemic. Infection and Drug Resistance. Volume 17. 3669–3675.
3.
Seki, Masafumi, Akira Satou, Tomoko Tamaki, et al.. (2024). Standardization of CD30 immunohistochemistry staining among three automated immunostaining platforms. Pathology International. 74(9). 530–537. 1 indexed citations
4.
Seki, Masafumi, et al.. (2024). Clinical Features of Patients with COVID-19 Recurrence During Hospitalization in the Omicron Variant Surge. Infection and Drug Resistance. Volume 17. 5011–5015.
5.
6.
Seki, Masafumi, et al.. (2023). COVID-19 and Listeria Meningitis Treated by Ampicillin, Sulfamethoxazole/Trimethoprim and Meropenem. Infection and Drug Resistance. Volume 16. 4289–4295. 1 indexed citations
7.
Seki, Masafumi, et al.. (2023). Antibiotic prescriptions for COVID-19 patients increased during the BA.5 period. Trends journal of sciences research. 2(1). 11–13. 1 indexed citations
8.
9.
Nomura, Jun, Masafumi Seki, Tadahiro Kobayashi, et al.. (2023). Progression of hemolysis in a patient with hereditary spherocytosis after the second dose of COVID-19 mRNA vaccine. Human Vaccines & Immunotherapeutics. 19(1). 2165381–2165381.
10.
Seki, Masafumi, et al.. (2023). Ensitrelvir improved SARS-CoV-2 viral titers of COVID-19 patients refractory to remdesivir. 3(1). 27–31. 1 indexed citations
11.
Watanabe, Yuji, et al.. (2022). Sinobronchial Syndrome Patients with Suspected Non-Tuberculous Mycobacterium Infection Exacerbated by Exophiala dermatitidis Infection. SHILAP Revista de lepidopterología. 6 indexed citations
12.
Seki, Masafumi, et al.. (2022). Sequential Treatment by Antiviral Drugs Followed by Immunosuppressive Agents for COVID-19 Patients with Hematological Malignancy. Infection and Drug Resistance. Volume 15. 7117–7124. 4 indexed citations
13.
Fukushi, Daisuke, et al.. (2022). Pulmonary and Disseminated Mycobacterium avium Complex Cases Confirmed by Tissue-Direct Polymerase Chain Reaction-Based Nucleic Acid Lateral Flow Immunoassay of Formalin-Fixed Paraffin-Embedded Tissues. SHILAP Revista de lepidopterología. 1 indexed citations
14.
Imai, Haruka, Yuji Watanabe, Jun Suzuki, et al.. (2021). Utility of a Cell-Direct Polymerase Chain Reaction-Based Nucleic Acid Lateral Flow Immunoassay for Detection of Bacteria in Peripheral Blood Leukocytes of Suspected Sepsis Cases. Infection and Drug Resistance. Volume 14. 5137–5144. 2 indexed citations
15.
16.
Seki, Masafumi. (2016). Management of aspiration pneumonia. 75(8). 838–844.
17.
Takazono, Takahiro, Koichi Izumikawa, Junji Tsurutani, et al.. (2009). Lemierre's Syndrome Followed by Acute Respiratory Distress Syndrome Successfully Rescued by Antibiotics and Hemoperfusion with Polymyxin B-Immobilized Fiber. Japanese Journal of Infectious Diseases. 62(2). 133–136. 5 indexed citations
18.
Seki, Masafumi, Shigeru Kohno, Michael W. Newstead, et al.. (2009). Critical Role of IL-1 Receptor-Associated Kinase-M in Regulating Chemokine-Dependent Deleterious Inflammation in Murine Influenza Pneumonia. The Journal of Immunology. 184(3). 1410–1418. 84 indexed citations
19.
Seki, Masafumi, Kohji Hashiguchi, Kosuke Kosai, et al.. (2006). A Patient with Fulminant Primary Influenza Pneumonia Which Developed into Secondary Bacterial Pneumonia. Acta medica Nagasakiensia. 51(4). 121–124. 6 indexed citations
20.
Kaneko, Yukihiro, Katsunori Yanagihara, Masafumi Seki, et al.. (2003). Clarithromycin inhibits overproduction of muc5ac core protein in murine model of diffuse panbronchiolitis. American Journal of Physiology-Lung Cellular and Molecular Physiology. 285(4). L847–L853. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshitomo Morinaga Breakdown of academic impact, for papers by Kazunori Tomono Breakdown of academic impact, for papers by June Myung Kim Breakdown of academic impact, for papers by Wolfgang Graninger Breakdown of academic impact, for papers by F. Jacobs Breakdown of academic impact, for papers by Hiroshi Kakeya Breakdown of academic impact, for papers by Markos Marangos Breakdown of academic impact, for papers by Yuka Yamagishi Breakdown of academic impact, for papers by José L. Pérez Breakdown of academic impact, for papers by Raymond P. Smith
Rankless by CCL
2026